VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
ALLISON, JAMES P
One or more keywords matched the following items that are connected to
ALLISON, JAMES P
Item Type
Name
Concept
B7-1 Antigen
Concept
B7-2 Antigen
Academic Article
B7x: a widely expressed B7 family member that inhibits T cell activation.
Academic Article
Restoring function in exhausted CD8 T cells during chronic viral infection.
Academic Article
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.
Academic Article
Immune modulation in cancer with antibodies.
Academic Article
CD28-B7 interactions in T-cell activation.
Academic Article
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Academic Article
CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Academic Article
T cell-mediated elimination of B7.2 transgenic B cells.
Academic Article
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.
Academic Article
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
Academic Article
B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
Academic Article
The B7 family and cancer therapy: costimulation and coinhibition.
Academic Article
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
Academic Article
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
Academic Article
Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells.
Academic Article
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
Academic Article
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
Academic Article
Inhibitors of B7-CD28 costimulation in urologic malignancies.
Academic Article
Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity.
Academic Article
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
Academic Article
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Academic Article
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Academic Article
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Academic Article
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
Concept
B7-H1 Antigen
Academic Article
Dissecting the mechanisms of immune checkpoint therapy.
Academic Article
Immune checkpoint therapy-current perspectives and future directions.
Search Criteria
B7 2 Antigen